Cutaquig

immunoglobulin G (human) for subcutaneous administration

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cutaquig, covering 2020-03-04 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

See pricing